vs
Agape ATP Corp（ATPC）与P3 Health Partners Inc.（PIII）财务数据对比。点击上方公司名可切换其他公司
P3 Health Partners Inc.的季度营收约是Agape ATP Corp的964.1倍（$384.8M vs $399.1K）。P3 Health Partners Inc.净利率更高（-19.6% vs -94.4%，领先74.8%）。Agape ATP Corp同比增速更快（10.9% vs 3.8%）。过去两年Agape ATP Corp的营收复合增速更高（11.9% vs -0.5%）
P3 Health Partners Inc.是一家总部位于美国的人口健康管理与价值型医疗服务企业，与基层医疗机构及医疗系统合作，为包括联邦医保优势计划参保者在内的人群提供协同优质医疗服务，致力于提升诊疗效果、降低不必要的医疗开支。
ATPC vs PIII — 直观对比
营收规模更大
PIII
是对方的964.1倍
$399.1K
营收增速更快
ATPC
高出7.1%
3.8%
净利率更高
PIII
高出74.8%
-94.4%
两年增速更快
ATPC
近两年复合增速
-0.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $399.1K | $384.8M |
| 净利润 | $-376.9K | $-75.5M |
| 毛利率 | 58.6% | — |
| 营业利润率 | -325.2% | -40.0% |
| 净利率 | -94.4% | -19.6% |
| 营收同比 | 10.9% | 3.8% |
| 净利润同比 | 53.4% | -28.8% |
| 每股收益（稀释后） | $-2.76 | $-23.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATPCPIII
| Q4 25 | $399.1K | $384.8M | ||
| Q3 25 | $370.6K | $345.3M | ||
| Q2 25 | $465.5K | $355.8M | ||
| Q1 25 | $289.0K | $373.2M | ||
| Q4 24 | $359.8K | $370.7M | ||
| Q3 24 | $331.3K | $362.1M | ||
| Q2 24 | $313.0K | $379.2M | ||
| Q1 24 | $318.6K | $388.5M |
净利润ATPCPIII
| Q4 25 | $-376.9K | $-75.5M | ||
| Q3 25 | $-586.8K | $-31.6M | ||
| Q2 25 | $-617.1K | $-20.4M | ||
| Q1 25 | $-698.9K | $-20.5M | ||
| Q4 24 | $-808.4K | $-58.6M | ||
| Q3 24 | $-509.6K | $-46.5M | ||
| Q2 24 | $-442.7K | $-12.0M | ||
| Q1 24 | $-709.7K | $-18.7M |
毛利率ATPCPIII
| Q4 25 | 58.6% | — | ||
| Q3 25 | 64.5% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 54.1% | — | ||
| Q4 24 | 49.5% | — | ||
| Q3 24 | 55.6% | — | ||
| Q2 24 | 61.8% | — | ||
| Q1 24 | 63.8% | — |
营业利润率ATPCPIII
| Q4 25 | -325.2% | -40.0% | ||
| Q3 25 | -162.3% | -12.8% | ||
| Q2 25 | -136.8% | -9.6% | ||
| Q1 25 | -249.2% | -10.2% | ||
| Q4 24 | -235.7% | -37.4% | ||
| Q3 24 | -165.4% | -29.5% | ||
| Q2 24 | -144.9% | -8.3% | ||
| Q1 24 | -227.1% | -11.3% |
净利率ATPCPIII
| Q4 25 | -94.4% | -19.6% | ||
| Q3 25 | -158.3% | -9.1% | ||
| Q2 25 | -132.6% | -5.7% | ||
| Q1 25 | -241.8% | -5.5% | ||
| Q4 24 | -224.7% | -15.8% | ||
| Q3 24 | -153.8% | -12.8% | ||
| Q2 24 | -141.4% | -3.2% | ||
| Q1 24 | -222.7% | -4.8% |
每股收益（稀释后）ATPCPIII
| Q4 25 | $-2.76 | $-23.08 | ||
| Q3 25 | $-0.01 | $-9.67 | ||
| Q2 25 | $-0.01 | $-6.23 | ||
| Q1 25 | $-0.07 | $-6.28 | ||
| Q4 24 | $-31.31 | $-23.13 | ||
| Q3 24 | $-0.13 | $-15.70 | ||
| Q2 24 | $-0.12 | $-7.37 | ||
| Q1 24 | $-0.18 | $-7.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $140.1K | $25.0M |
| 总债务越低越好 | — | $228.4M |
| 股东权益账面价值 | $22.5M | $-155.2M |
| 总资产 | $24.6M | $656.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATPCPIII
| Q4 25 | $140.1K | $25.0M | ||
| Q3 25 | $133.7K | $37.7M | ||
| Q2 25 | $216.0K | $38.6M | ||
| Q1 25 | $578.8K | $40.1M | ||
| Q4 24 | $2.0M | $38.8M | ||
| Q3 24 | $2.7M | $63.0M | ||
| Q2 24 | $3.2M | $73.1M | ||
| Q1 24 | $3.6M | $27.3M |
总债务ATPCPIII
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
股东权益ATPCPIII
| Q4 25 | $22.5M | $-155.2M | ||
| Q3 25 | $22.8M | $-18.7M | ||
| Q2 25 | $23.4M | $44.5M | ||
| Q1 25 | $24.0M | $63.3M | ||
| Q4 24 | $1.9M | $75.9M | ||
| Q3 24 | $2.7M | $120.5M | ||
| Q2 24 | $3.2M | $166.8M | ||
| Q1 24 | $3.7M | $146.6M |
总资产ATPCPIII
| Q4 25 | $24.6M | $656.6M | ||
| Q3 25 | $24.4M | $683.6M | ||
| Q2 25 | $24.7M | $731.6M | ||
| Q1 25 | $25.2M | $783.9M | ||
| Q4 24 | $3.2M | $783.4M | ||
| Q3 24 | $4.0M | $833.3M | ||
| Q2 24 | $4.3M | $892.8M | ||
| Q1 24 | $4.8M | $855.9M |
负债/权益比ATPCPIII
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-208.3K | $-25.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ATPCPIII
| Q4 25 | $-208.3K | $-25.7M | ||
| Q3 25 | $-256.7K | $-15.4M | ||
| Q2 25 | $-494.5K | $-16.6M | ||
| Q1 25 | $-1.5M | $-33.5M | ||
| Q4 24 | $-645.3K | $-57.2M | ||
| Q3 24 | $-424.9K | $-22.6M | ||
| Q2 24 | $-412.5K | $-10.2M | ||
| Q1 24 | $-1.2M | $-20.0M |
资本支出强度ATPCPIII
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATPC
暂无分部数据
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
